Valerio Rosato

17PUBLICATIONS
81CO-AUTHORS
PharmacogenomicsPolitical economy and social changeMajor global burdens of diseaseToxicology (incl. clinical toxicology)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Nov 27, 2025
Epidemiologic Characteristics Determining the Choice of Direct-Acting Antiviral Therapy in HCV Patients: An Italian Real-World Evidence Study.

Nicola Pugliese, Fabio Conti, Valerio Rosato

|Sep 04, 2025
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World Database.

Alessandro Loglio, Ivan Gardini, Massimiliano Conforti

|Feb 26, 2025
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study.

Luca Rinaldi, Mauro Viganò, Alessia Ciancio

|Oct 16, 2024
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration.

Valerio Rosato, Riccardo Nevola, Marcello Dallio

|Jul 13, 2024
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study.

Paolo Gallo, Antonio De Vincentis, Francesca Terracciani

|Jul 29, 2023
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma.

Riccardo Nevola, Giovanni Tortorella, Valerio Rosato

Pageof 3

Frequent Collaborators

9 joint publications

Riccardo Nevola

6 joint publications

Alessandro Federico

4 joint publications

Marcello Dallio

4 joint publications

Loreta Anesti Kondili